Accession Number : ADA187423

Title :   Army Drug Development Program. Phase 1. Clinical Testing.

Descriptive Note : Annual rept. Jan-Aug 83,

Corporate Author : BIO-MED INC COLLEGE PARK MD

Personal Author(s) : Reba, Richard C

PDF Url : ADA187423

Report Date : Apr 1985

Pagination or Media Count : 103

Abstract : Results are presented for Phase I Clinical Studies: The Army Drug Development Program . Activities include Experiment 21, WR 2HC1: Short Term Safety and Tolerance Study and Experiment 22, The Effect of Low and High Caloric Diet upon the SGOT and SGPT of Normal Human Subjects. Keywords: Antimalarials, Leishmaniasis, WR 6026 2HC1, Hepatic enzymes, Abate, Diet, Human subjects, Serum glutamic oxaloacetic transaminase(SGOT), Serum glutamic pyruvic transaminase(SGPT).

Descriptors :   *ANTIMALARIALS, *DRUG TOLERANCE, AMINOTRANSFERASES, ARMY, CALORIFIC VALUE, CLINICAL MEDICINE, DIET, DRUGS, ENZYMES, HUMANS, LEISHMANIASIS, LIVER, PHASE STUDIES, TEST AND EVALUATION, TOXIC TOLERANCES

Subject Categories : Pharmacology

Distribution Statement : APPROVED FOR PUBLIC RELEASE